NEW YORK CITY, NY / ACCESS Newswire / June 9, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Fulgent Genetics, Inc. ("Fulgent" or the "Company") (NASDAQ:FLGT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT

NEW YORK, NY / ACCESS Newswire / June 9, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Schrödinger, Inc.("Schrödinger" or the "Company") (NASDAQ:SDGR). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR

NEW YORK CITY, NY / ACCESS Newswire / June 9, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Luminar Technologies, Inc. ("Luminar" or the "Company") (NASDAQ:LAZR). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Luminar Technologies, Inc. - LAZR

NEW YORK CITY, NY / ACCESS Newswire / June 9, 2025 / Pomerantz LLP is investigating claims on behalf of investors of NeuroPace, Inc. ("NeuroPace" or the "Company") (NASDAQ:NPCE). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCE

NEW YORK, NY / ACCESS Newswire / June 9, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Tempus AI, Inc.("Tempus" or the "Company") (NASDAQ:TEM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tempus AI, Inc. - TEM

NEW YORK CITY, NY / ACCESS Newswire / June 9, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Travere Therapeutics, Inc. ("Travere" or the "Company") (NASDAQ:TVTX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Travere Therapeutics, Inc. - TVTX

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN ) 46th Annual Goldman Sachs Global Healthcare Conference June 9, 2025 10:40 AM ET Company Participants Christopher R. Fenimore - Executive VP of Finance & CFO Ryan Crowe - Senior Vice President of Investor Relations & Strategic Analysis Conference Call Participants Salveen Jaswal Richter - Goldman Sachs Group, Inc., Research Division Salveen Jaswal Richter Great.

image for news Regeneron Pharmaceuticals, Inc. (REGN) Presents at 46th Annual Goldman Sachs Global Healthcare Conference Transcript

Marathon CEO Bruce Richards: How can you not be bullish on Wells Fargo — Positive

WFC   CNBC Television — June 09, 2025

Bruce Richards, Marathon Asset Management CEO, joins 'Money Movers' to discuss equities, private credit and markets adjusting to tariffs.

image for news Marathon CEO Bruce Richards: How can you not be bullish on Wells Fargo

Chewy: Debt-Free Online Pet Retailer - Initiate With Buy Rating — Positive

CHWY   Seeking Alpha — June 09, 2025

I rate Chewy, Inc. a Buy with a $60 fair value, due to strong topline growth and margin expansion potential in the expanding pet market. Chewy benefits from rising online pet product sales, robust customer acquisition, and increased spending per active customer, especially via its Autoship program. Strategic expansion into private brands and pet vet services, plus a debt-free balance sheet, supports long-term growth and margin improvement.

image for news Chewy: Debt-Free Online Pet Retailer - Initiate With Buy Rating

NEW YORK CITY, NY / ACCESS Newswire / June 9, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Rocket Pharmaceuticals, Inc. ("Rocket" or the "Company") (NASDAQ:RCKT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rocket Pharmaceuticals, Inc. - RCKT

Tesla stock is in focus as investors wait for the company's robotaxi event on Thursday. The autonomous taxi launch comes just after CEO Elon Musk and US President Trump's public fallout.

image for news Elon Musk's Trump ties backfired for Tesla investors: Could the robotaxi turn things around?

Academy Sports and Outdoors, Inc. ASO will release its first-quarter financial results before the opening bell on Tuesday, June 10.

image for news Top Wall Street Forecasters Revamp Academy Sports and Outdoors Expectations Ahead Of Q1 Earnings

The media conglomerate will divvy up its assets in movies, TV, gaming and other areas into two companies: Streaming & Studios and Global Networks.

image for news Warner Bros. Discovery Is Splitting Up: What It Means for You

Gold pauses to start trading week — Neutral

AAAU  BAR  DBP  DGL  GLD  GLDM  IAU  OUNZ  SGOL  UGL   Kitco — June 09, 2025

Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York.

image for news Gold pauses to start trading week

Zacks Initiates Coverage of Ampco-Pittsburgh With Neutral Recommendation — Neutral

AP   Zacks Investment Research — June 09, 2025

Discover why Zacks rates Ampco-Pittsburgh as "Neutral", being the first on Wall Street to initiate coverage on the stock. Explore AP's promising growth prospects and financial health amid market challenges.

image for news Zacks Initiates Coverage of Ampco-Pittsburgh With Neutral Recommendation

Zacks Industry Outlook Penumbra, Integer and AngioDynamics — Negative

ANGO  ITGR  PEN   Zacks Investment Research — June 09, 2025

Zacks names PEN, ITGR and ANGO as medical device stocks riding genAI advances, despite global and inflationary headwinds.

image for news Zacks Industry Outlook Penumbra, Integer and AngioDynamics

DD Adds Sterile Packaging Capacity at Costa Rica Manufacturing Plant — Positive

DD   Zacks Investment Research — June 09, 2025

DuPont's Costa Rica expansion introduces sterile healthcare packaging, a first for the region's medical device industry.

image for news DD Adds Sterile Packaging Capacity at Costa Rica Manufacturing Plant

Top Stock Movers Now: Warner Bros. Discovery, Boeing, Sunnova, and more — Neutral

BA  NOVA  WBD   Investopedia — June 09, 2025

U.S. equities were mixed and little changed at midday as the markets awaited any news from the trade talks between the U.S. and China that began today. The S&P 500 and Nasdaq rose, but the Dow Jones Industrial Average fell.

image for news Top Stock Movers Now: Warner Bros. Discovery, Boeing, Sunnova, and more

TORONTO , June 9, 2025 /PRNewswire/ - Collective Mining Ltd. (NYSE: CNL) (TSX: CNL) ("Collective" or the "Company") is pleased to announce that Mr.

image for news Collective Mining Announces the Appointment of Raphael Maracajá as Vice President Mining

Cathie Wood Comeback: These 2 Ark ETFs are Sailing Higher Again — Positive

ARKG  ARKK   24/7 Wall Street — June 09, 2025

It's probably time to give Cathie Wood the benefit of the doubt as the tides turn back in disruptive innovation's favor.

image for news Cathie Wood Comeback: These 2 Ark ETFs are Sailing Higher Again